ZFP69 zinc finger protein B (ZFP69B)

ZFP69B (ZFP69 zinc finger protein B), also known as ZNF643, is a KRAB-domain containing zinc finger transcription factor with a documented role in chromatin remodeling and transcriptional regulation[1][3]. It is upregulated in diverse cancers, correlating with cell migration, invasion, cell cycle progression, and adverse prognosis[1][2]. ZFP69B is involved in a variety of pathways including cell adhesion and immune signaling, and may be connected to ferroptosis-related processes. The protein’s exact functional mechanisms are still under investigation, but it binds to regulatory regions of DNA, modifying gene expression profiles relevant to tumorigenesis[1][2][3]. Notes/Limitations: - The term "ZFP69B divergent transcript" or "ZFP69B-DT" does not correspond to a recognized therapeutic target in authoritative biomedical literature or curated gene/protein databases. - "Divergent transcript" generally refers to non-coding RNAs transcribed from the opposite strand near gene promoters, often as long non-coding RNAs (lncRNAs), involved in gene regulation, but not established as drug targets themselves[5]. - The functional and disease associations provided above refer to the **protein-coding gene ZFP69B/ZNF643**, not specifically to any divergent transcript at that locus. - If a lncRNA or specific divergent transcript has been annotated and demonstrates functional relevance, it should have a clear, separate entry in gene/RNA databases—no such entry is available for "ZFP69B-DT." Summary determination: "ZFP69B divergent transcript" (ZFP69B-DT) is not a standard, actionable molecular target. Information refers to the protein-coding ZFP69B gene (a transcription factor with oncogenic roles), but not to a distinct therapeutic target matching the query text. If your use case refers to the protein-coding transcription factor or its role in cancer, use "ZFP69 zinc finger protein B (ZFP69B, ZNF643)." If it refers to a regulatory lncRNA or non-coding transcript, be aware that this is not an established therapeutic target and requires further characterization.[1][2][3][5]

Other names

ZNF643ZFP69BZFP69

Not applicable (no known drugs target ZFP69B directly as of current knowledge)